ITM2A Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6765a
Background:
ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes.
Other Names:
Integral membrane protein 2A, Protein E25, ITM2A
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6765a was selected from the N-term region of human ITM2A. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ITM2A
Gene ID: 9452
Primary Accession: O43736
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes.
Other Names:
Integral membrane protein 2A, Protein E25, ITM2A
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6765a was selected from the N-term region of human ITM2A. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ITM2A
Gene ID: 9452
Primary Accession: O43736
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review